Is Pentraxin 3 A Marker in Pathogenesis of Metabolic Syndrome?

Carmine Finelli
Additional contact information
Carmine Finelli: Department of Internal Medicine, Ospedale Cav. R. Apicella – ASL Napoli 3 Sud, Via di Massa, 1, 80040 Pollena (Napoli), Italy

Biomedical Journal of Scientific & Technical Research, 2021, vol. 38, issue 2, 30144-30146

Abstract: Pentraxin 3 (PTX3) is an acute-phase protein that is structurally similar to C-reactive protein (CRP). Macrophages, endothelial cells, and adipocytes all produce PTX3 in response to inflammatory stimuli, but hepatocytes are the main source of CRP.

Keywords: Covid-19; Infectious Disease; Disease Control; Incubation Period; Spread Rate of Covid-19; Population; Unemployment Tradeoff; Virus; Vaccines; Covid-19 Mutation (search for similar items in EconPapers)
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.006117.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.006117.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:38:y:2021:i:2:p:30144-30146

DOI: 10.26717/BJSTR.2021.38.006117

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().